EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of a novel anti-angiogenic regulatory sequence within the syndecan-3 extracellular core protein

Samantha Arokiasamy iD, Giulia De Rossi iD, Thomas C Moseley, Sylvie Ricard-Blum iD, James R Whiteford iD

Journal of Cell Science · 11.11.2026

DOI: 10.1242/jcs.265258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Science, online erschienen am 11.11.2026. Verfasst von Samantha Arokiasamy und 4 weiteren Autor:innen. Beteiligte Einrichtung: William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Londo…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Barts Charity, Versus Arthritis, Dunhill Medical Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Syndecans are transmembrane proteoglycans that regulate angiogenesis through their glycosaminoglycan chains and core proteins. We previously demonstrated that the syndecan-3 (SDC3) extracellular core protein possesses anti-angiogenic activity independent of its glycosaminoglycan chains. Here, using recombinant truncation mutants, endothelial migration assays and peptide mapping, we localised this activity and identified a minimal nine amino acid peptide, QM111, that retained full biological activity. QM111 inhibited endothelial cell migration and angiogenic sprouting in rat aortic ring and mouse choroidal explant models. Intrinsic disorder analysis revealed that QM111 resides within a region of comparatively reduced disorder, consistent with other syndecan regulatory sequences. QM111 did not induce inflammatory chemokine production, exhibited no detectable cytotoxicity, and retained substantial stability in human serum and vitreous humour. QM111 displayed anti-angiogenic activity comparable to the previously described syndecan-2-derived peptide QM107, with combination treatment producing robust inhibition of angiogenesis. These findings identify a novel anti-angiogenic regulatory sequence within SDC3 and support the concept that syndecan extracellular core proteins contain biologically active sequences with potential therapeutic utility.

Schlagwörter

Stichwörter der Autor:innen

AngiogenesisExtracellular matrixProteoglycanSyndecan

Autor:innen und Institutionen

  • William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Institute of Ophthalmology, University College London,11-43 Bath Street, London EC1V 9EL, UK.
  • Université Lyon 1, CNRS, ICBMS, UMR 5246, Villeurbanne, France.

ORCID-Profile: Samantha Arokiasamy, Giulia De Rossi, Sylvie Ricard-Blum, James R Whiteford

Förderung

  • Barts Charity
  • Versus Arthritis
  • Dunhill Medical Trust

Zitieren

APA

Arokiasamy, S., De Rossi, G., Moseley, T. C., Ricard-Blum, S., & Whiteford, J. R. (2026). Identification of a novel anti-angiogenic regulatory sequence within the syndecan-3 extracellular core protein. Journal of Cell Science. https://doi.org/10.1242/jcs.265258

Vancouver

Arokiasamy S, De Rossi G, Moseley TC, Ricard-Blum S, Whiteford JR. Identification of a novel anti-angiogenic regulatory sequence within the syndecan-3 extracellular core protein. Journal of Cell Science. 2026. doi:10.1242/jcs.265258

BibTeX
@article{Arokiasamy2026,
  author = {Arokiasamy, Samantha and De Rossi, Giulia and Moseley, Thomas C and Ricard-Blum, Sylvie and Whiteford, James R},
  title = {Identification of a novel anti-angiogenic regulatory sequence within the syndecan-3 extracellular core protein},
  journal = {Journal of Cell Science},
  year = {2026},
  doi = {10.1242/jcs.265258}
}
Kostenlos starten →